Bulk Manufacturer of Controlled Substances Registration, 34695-34696 [2017-15692]
Download as PDF
<![CDATA[
34695
Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices
Dated: July 20, 2017.
Demetra Ashley,
Acting Assistant Administrator.
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before September 25, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
[FR Doc. 2017–15693 Filed 7–25–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
ACTION:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
SUPPLEMENTARY INFORMATION:
Bulk Manufacturer of Controlled
Substances Application: AMRI
Rensselaer, Inc.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
30, 2017, AMRI Rensselaer, Inc., 33
Riverside Avenue, Rensselaer, New
York 12144 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Drug code
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Lisdexamfetamine ............................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Codeine ...........................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Morphine ..........................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
product development and for
distribution to its customers.
In reference to drug codes 7360
(marihuana) and 7370 (THC), the
company plans to bulk manufacture
these drugs as synthetics. No other
activities for these drug codes are
authorized for this registration.
Dated: July 19, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–15688 Filed 7–25–17; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
Notice of registration.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturers of various classes of
controlled substances.
SUMMARY:
Cedarburg Pharmaceuticals ......................................................................................
Siegfried USA, LLC ...................................................................................................
Sigma Aldrich Research Biochemicals, Inc ..............................................................
mstockstill on DSK30JT082PROD with NOTICES
FR docket
82 FR 19083 ...........................................
82 FR 19084 ...........................................
82 FR 19085 ...........................................
VerDate Sep<11>2014
17:49 Jul 25, 2017
Jkt 241001
I
I
II
II
II
II
II
II
II
II
II
II
II
II
The
companies listed below applied to be
registered as manufacturers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
for these notices.
Company
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
7360
7370
1100
1205
1724
2270
8333
9050
9143
9150
9193
9230
9300
9801
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
ACTION:
Schedule
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
Published
April 25, 2017.
April 25, 2017.
April 25, 2017.
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
E:\FR\FM\26JYN1.SGM
26JYN1
34696
Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices
Dated: July 19, 2017.
Demetra Ashley,
Acting Assistant Administrator.
registration as a bulk manufacturer to
the above listed persons.
Dated: July 19, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–15690 Filed 7–25–17; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2017–15692 Filed 7–25–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Drug Enforcement Administration
Importer of Controlled Substances
Application: AMRI Rensselaer, Inc.
[Docket No. DEA–392]
ACTION:
Bulk Manufacturer of Controlled
Substances Application: Organic
Consultants, Inc.
ACTION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before September 25, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 2, 2016, Organic Consultants,
Inc., 90 North Polk Street, Suite 200,
Eugene, Oregon 97402 applied to be
registered as a bulk manufacturer for
methadone intermediate (9254), a basic
class of controlled substance listed in
schedule II.
The company plans to manufacture
analytical reference standards for
distribution to its customers for research
and analytical purposes.
mstockstill on DSK30JT082PROD with NOTICES
VerDate Sep<11>2014
17:49 Jul 25, 2017
Jkt 241001
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before August 25, 2017. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before August 25,
2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
DATES:
Notice of application.
SUPPLEMENTARY INFORMATION:
Notice of application.
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June
27, 2016, AMRI Rensselaer, Inc., 33
Riverside Avenue, Rensselaer, New
York 12144 applied to be registered as
an importer of poppy straw concentrate
(9670), a basic class of controlled
substance listed in schedule II.
The company plans to import the
listed controlled substance to
manufacture bulk controlled substance
for distribution to its customers.
Dated: July 20, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–15689 Filed 7–25–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Employment and Training
Administration
Workforce Information Advisory
Council
Employment and Training
Administration, Labor.
ACTION: Notice of Renewal of the
Workforce Information Advisory
Council.
AGENCY:
The Department of Labor
(Department) announces the renewal of
the Workforce Information Advisory
Council (WIAC) charter.
FOR FURTHER INFORMATION CONTACT:
Steve Rietzke, Division of National
Programs, Tools, and Technical
Assistance, Office of Workforce
Investment, Rm. C–4510, 200
Constitution Ave. NW., Washington, DC
20212–0001; (202) 693–3912; or use
email address for the WIAC, WIAC@
dol.gov.
SUMMARY:
SUPPLEMENTARY INFORMATION:
I. Background and Authority
Section 15 of the Wagner-Peyser Act,
29 U.S.C. 49l–2, as amended by section
308 of the Workforce Innovation and
Opportunity Act of 2014 (WIOA), Public
Law 113–128 requires the Secretary of
Labor (Secretary) to establish and
maintain the WIAC.
The statute, as amended, requires the
Secretary, acting through the
Commissioner of Labor Statistics and
the Assistant Secretary for Employment
and Training, to formally consult at
least twice annually with the WIAC to
address: (1) Evaluation and
improvement of the nationwide
workforce and labor market information
system established by the Wagner-
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 82, Number 142 (Wednesday, July 26, 2017)]
[Notices]
[Pages 34695-34696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15692]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as bulk
manufacturers of various classes of controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as manufacturers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted for these
notices.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
Cedarburg Pharmaceuticals..... 82 FR 19083..... April 25, 2017.
Siegfried USA, LLC............ 82 FR 19084..... April 25, 2017.
Sigma Aldrich Research 82 FR 19085..... April 25, 2017.
Biochemicals, Inc.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of these registrants to manufacture
the applicable basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each of the company's maintenance of
effective controls against diversion by inspecting and testing each
company's physical security systems, verifying each company's
compliance with state and local laws, and reviewing each company's
background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a
[[Page 34696]]
registration as a bulk manufacturer to the above listed persons.
Dated: July 19, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-15692 Filed 7-25-17; 8:45 am]
BILLING CODE 4410-09-P
